NCT02192554View on ClinicalTrials.gov

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Agitation Associated With Alzheimer's DiseaseAlzheimer's TypeMental DisorderNervous System Diseases
Trial Locations (84)

1000

Ljubljana

1113

Sofia

1431

Sofia

2000

Maribor

5000

Veliko Tarnovo

5290

Šempeter pri Gorici

6600

Kardzhali

7003

Rousse

8000

Burgas

9020

Varna

9648

Mittweida

10000

Zagreb

10090

Zagreb

11000

Belgrade

11040

New Hyde Park

11214

Brooklyn

12209

Berlin

18000

Niš

21000

Novi Sad

21005

Vinnytsia

23330

Novi Kneževac

26220

Kovin

26655

Westerstede

27609

Raleigh

28270

Charlotte

28601

Hickory

30024

Suwanee

30331

Atlanta

31014

Pamplona

31059

Toulouse

32763

Orange City

33012

Hialeah

33018

Hialeah

33122

Miami

33126

Miami

33137

Miami

33161

North Miami

33166

Miami Springs

33175

Miami

34000

Kragujevac

34205

Bradenton

34239

Sarasota

35006

Odesa

35404

Tuscaloosa

36013

Poltava

37004

Salamanca

44791

Bochum

46010

Valencia

46026

Valencia

49021

Zamora

50935

Cologne

53188

Waukesha

59500

Douai

61068

Kharkiv

63128

St Louis

67513

Odesa

73488

Kherson

75243

Dallas

78990

Élancourt

79021

Lviv

90805

Lakewood

92373

Redlands

92626

Costa Mesa

92868

Orange

190000

Saint Petersburg

190005

Saint Petersburg

191040

Saint Petersburg

191119

Saint Petersburg

192019

Saint Petersburg

195176

Saint Petersburg

197341

Saint Petersburg

198510

Saint Petersburg

357034

Tonnelniy

410060

Saratov

443016

Samara

620030

Yekaterinburg

02169

Quincy

08755

Toms River

V2A 4M4

Penticton

B4N 4K9

Kentville

01012

Bourg N Bresse

04080

Kiev

04114

Kiev

PL11 2TB

Torpoint

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT02192554 - Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo | Biotech Hunter | Biotech Hunter